Effects of cyclosporine on immunologic mechanisms in psoriasis
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 23 (6) , 1318-1328
- https://doi.org/10.1016/0190-9622(90)70360-t
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Intralesional cyclosporine in the treatment of psoriasis: A clinical, immunologic, and pharmacokinetic studyJournal of the American Academy of Dermatology, 1990
- Remission of psoriatic lesions with muromonab-CD3 (Orthoclone OKT3) treatmentJournal of the American Academy of Dermatology, 1989
- Epidermal Keratiocytes Express the Adhesion Molecule Intercellular Adhesion Molecule-1 in Inflammatory Dermatoses.Journal of Investigative Dermatology, 1989
- Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factorJournal of the American Academy of Dermatology, 1989
- Predominance of ?memory? T cells (CD4+, CDw29+) over ?naive? T cells (CD4+, CD45R+) in both normal and diseased human skinArchives of Dermatological Research, 1989
- Chemotactic Factors for Macrophages Produced in Inflamed SkinDermatology, 1989
- Inhibition of Histamine and Prostaglandin D2 Release from Human Lung Mast Cells by Ciclosporin AInternational Archives of Allergy and Immunology, 1989
- Treatment of resistant severe psoriasis with systemic cyclosporineJournal of the American Academy of Dermatology, 1987
- INHIBITION OF THE ACCESSORY FUNCTION OF MURINE MACROPHAGES IN VITRO BY CYCLOSPORINETransplantation, 1985
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979